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Continued favorable results with open surgical
repair of type IV thoracoabdominal aortic
aneurysms
Virendra I. Patel, MD, Emel Ergul, MS, Mark F. Conrad, MD, Matthew Cambria, MD,
Glenn M. LaMuraglia, MD, Christopher J. Kwolek, MD, David C. Brewster, MD, and
Richard P. Cambria, MD, Boston, Mass
Objectives: Type IV thoracoabdominal aortic aneurysm (TAAA) repair, despite low risk of spinal cord ischemia (SCI), is
reported to have significant morbidity and mortality. This has led some to apply adjuncts (eg, extracorporeal circulation)
used in more extensive TAAA repair or to consider alternative approaches, such as hybrid operations. We have used a
consistent, simplified surgical approach to type IV TAAA, and the goal of the present study is to review experience over
2 decades with such treatment and to identify correlates of surgical morbidity.
Methods: All type IV repairs at Massachusetts General Hospital from January 1989 through September 2009 were
evaluated for clinical features, technical operative details, and 30-day outcomes. Logistic regression identified predictors
of morbidity. Survival was assessed using Kaplan-Meier analysis.
Results: A total of 179 patients underwent type IV repair, with elective repair in 156 (87%) and urgent in 23 (13%). The
clamp-and-sew technique was used for all operations, with routine hypothermic renal perfusion. Clinical features were
age 73  8 years, coronary artery disease in 89 (50%), and creatinine level >1.8 mg/dL defining chronic renal
insufficiency (CRI) in 32 (18%). Operative reconstruction in 166 (93%) consisted of one beveled proximal anastomosis
incorporating the descending thoracic aorta, celiac, superior mesenteric artery, and right renal arteries origins (mean
visceral clamp time, 36  12 minutes) and a side-arm graft to the left renal artery. Technical details included previous
abdominal aortic aneurysm (AAA) repair in 52 (29%), operative time of 290 90 min, estimated blood loss of 2.7 1.4
L, and splenectomy in 57 (32%). The 30-day outcomes were death in 5 (2.8%), myocardial infarction in 6 (3.4%),
hemodialysis in 5 (2.8%), and any degree of SCI in 4 (2.2%). Regression analysis identified a history of CRI as an
independent predictor of postoperative complication or death (odds ratio, 3.4; 95% confidence interval, 1.4-8). Survival
rates at 1, 5, and 10 years were 89%  2%, 62%  4%, and 36%  5%, respectively.
Conclusions: A simplified operative approach for type IV TAAA repair is associated with favorable perioperative results.
These data refute the need for surgical adjuncts commonly applied in more extensive TAAA and indicate that the hybrid
operation is an illogical posture. CRI should figure prominently in clinical decision making. Long-term survival equates
that observed after routine AAA repair. ( J Vasc Surg 2011;53:1492-8.)
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aThe outcomes of type IV repair evaluated in the context
of other thoracoabdominal aortic aneurysm (TAAA) types
are often reported as favorable in comparison; there is
consensus that spinal cord ischemia (SCI) is uncommon in
type IV repair.1-4 Type I to III TAAAs are often repaired
with distal perfusion techniques or neuromonitoring, or
both; however, the use of such adjuncts is irregularly ap-
plied in the repair of type IV TAAA.4-6 A variety of opera-
tive considerations, including less extensive thoracotomy,
avoiding both paralysis of the left hemidiaphragm and
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1492esection of the lower half of the descending thoracic aorta
DTA), support the intuitively logical position that type IV
epair is of lesser magnitude, yet some reports detail signif-
cant mortality rates of 3% to 20%.5-7 Our overall experi-
nce has suggested a significantly diminished morbidity
ate for type IV vs extent types I to III repair; accordingly,
e evaluated outcomes after type IV TAAA repair per-
ormed with a consistently applied simplified surgical tech-
ique.
ETHODS
We performed a retrospective analysis of all consecutive
ype IV repairs performed at Massachusetts General Hos-
ital (MGH) from January 1989 through September 2009,
fter approval by the MGH Institutional Review Board.
atient data for all thoracic aortic procedures is prospec-
ively entered into our institutional Thoracic Aortic Center
TAC) database. TAC data are independently verified and
alidated by clinical nurses who maintain data integrity.
he Crawford classification and all patient data were addi-
ionally validated with a retrospectivemedical record review
s a part of this study. Specifics of type IV designation vs
uprarenal abdominal aortic aneurysm (AAA) or extent III
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Volume 53, Number 6 Patel et al 1493TAAA, or both, for example, have been reviewed else-
where.8 In brief, type IV TAAA (also known as total AAA)
involves the entire visceral aortic segment, such that repair
involves graft replacement cephalad to the celiac axis.
The effects of demographic factors on outcomes were
studied. Renal function was evaluated using preoperative
serum creatinine (mg/dL) and the preoperative estimated
glomerular filtration rate (eGFR), which was calculated
using modified diet in renal disease equation (gender factor
 186  creatinine–1.154  age–0.204).9
Definitions. Chronic renal insufficiency (CRI) was
defined as a baseline serum creatinine 1.8 mg/dL. Cor-
onary artery disease (CAD) was defined as a history of
myocardial infarction, positive result on a cardiac stress test,
or a previous percutaneous or open surgical coronary artery
revascularization. Peripheral vascular disease (PVD) was
defined as a history of intermittent claudication, ischemic
rest pain, ischemic gangrene or tissue loss, and a history of
percutaneous or open surgical revascularization of the
lower extremity arterial circulation.
Aneurysm-related features included family history of
aneurysm diameter (cm), previous aneurysm repair, pathol-
ogy, urgent vs elective repair, and ruptured status. Aneu-
rysm repair was referred to as urgent in patients who
presented with symptoms referable to the type IV TAAA
and who underwent repair 24 to 48 hours of hospital
admission. All other repairs were elective. The aneurysm
was referred to as ruptured according to loss of aneurysm
integrity with retroperitoneal hematoma on preoperative
computed tomography angiogram or intraoperative find-
ings.
Operative details. Type IV reconstructions are typi-
cally performed through a transpleural, transabdominal,
diaphragm-sparing thoracoabdominal incision in the sev-
enth to ninth intercostal space. Anatomy permitting, our
preferred construct is a beveled proximal suture line that
has a posterior inferior aspect beginning at or into the right
renal artery origin, with suture bites as close to the visceral
vessel origins as possible to maximally exclude aneurysmal
tissue. Superiorly, the graft itself extends cephalad to the
celiac axis. This reconstructive strategy implies the “heel”
of the anastomosis will be coursing around the right renal
artery, and in circumstances of the suture line potentially
compromising the right renal artery origin or when signif-
icant right renal artery stenosis exists, direct placement of a
balloon expandable stent is performed, as previously de-
scribed.10,11
Aortic grafts are prefashioned with a side arm for the
left renal artery reconstruction before cross-clamp applica-
tion. Renal preservation is achieved through direct instilla-
tion of renal preservation fluid, comprising 4°C lactated
Ringer’s solution with mannitol (25 g/L) and methyl
prednisolone (1 g/L), into the renal artery ostia after the
aorta is opened. Surgical adjuncts, such as cerebrospinal
fluid drainage (CSFD), were used at the surgeon’s discre-
tion. Clamp-and-sew was the approach in 99% of cases.
Outcomes and complications. Operative mortality
was defined as any in-hospital death. Complications evaluated dn the present study included cardiac and pulmonary compli-
ations, hemodialysis-dependent renal failure (end-stage renal
isease), other renal complications, re-exploration, SCI, mul-
iple organ dysfunction syndrome, and septic shock. Com-
osite cardiac complications included myocardial infarc-
ion, congestive heart failure, arrhythmia, and cardiac
rrest. Pulmonary complications included prolonged ven-
ilation (48 hours), reintubation, need for tracheostomy,
nd pneumonia. Renal complications were graded as he-
odialysis-dependent renal failure and acute renal failure,
efined as doubling of serum creatinine or a creatinine level
3.0 mg/dL without hemodialysis, as previously de-
cribed.11 Any renal complication also included patients
ith acute tubular necrosis, defined as a transient rise in
erum creatinine returning to baseline value. Long-term
urvival data from the Social Security Death Index were
athered using patient Social Security Numbers or patient
ame and date of birth.
Statistical analysis. Categoric demographic data and
linical features are presented as the percentage prevalence
n the study population. Mean data are presented as mean
standard deviation. Statistical analysis was performed by
sing two-tailed t tests for continuous variables and 2
nalysis for categoric data. Long-term survival was evalu-
ted by Kaplan-Meier analysis. Univariate and multivariate
egression analyses were performed to identify predictors of
eath, any complication, cardiac complications, pulmonary
omplications, and renal complications. Cox proportional
azard analysis was used to evaluate for predictors of long-
erm survival. Results with a P .05 were considered statisti-
ally significant. Statistical analysis of the data was performed
sing SPSS 15.0 software (SPSS Inc, Chicago, Ill).
ESULTS
During the study period, 179 patients underwent type
V repair. Clinical and demographic features are summa-
ized in Table I. Elective repair was performed in 154
atients (87%), with 24 (13%) requiring urgent repair, of
hich 8% had a ruptured type IV TAAA (Table II). Of the
2 patients (29%) with prior aneurysm repair, 47 (90%)
ere prior infrarenal AAA repairs. Standard reconstruction
ith a beveled proximal anastomosis was performed in 166
93%) with CSFD in 27 (15%), open right renal artery
tenting in 33 (19%), and splenectomy in 57 (32%) patients
any capsular tear is managed with splenectomy to avoid
elayed hemorrhage; Table III). Two patients were treated
ith distal aortic perfusion in the setting of CRI and the
eed for a separate end-to-end proximal aortic anastomosis
o the DTA. Visceral and left renal ischemia times were 36
12 and 57 19minutes, respectively (Table III). Details
egarding blood turnover and intraoperative transfusion
equirements are summarized in Table III.
Total intensive care unit and hospital lengths of stay
fter type IV TAAA repair were 4.4 10 and 12 9 days,
espectively. Five patients (2.8%) died in the hospital. SCI
eveloped in four patients (2.2%), and hemodialysis-
ependent renal failure developed in five (2.8%; Table IV).
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June 20111494 Patel et alIn the four patients with SCI, paraplegia or paraparesis
developed in two patients each.
One of the two patients with paraplegia underwent
attempted repair for a ruptured type IV TAAA at another
institution and was transferred toMGH for definitive repair
with an open/packed abdomen. This patient underwent
emergent repair, immediate paraplegia developed, and the
patient died in the postoperative setting.
The second patient with paraplegia underwent type IV
TAAA repair in the setting of rapid enlargement with a
history of ESRD. Paraplegia developed on postoperative
day 6 after development of retroperitoneal bleeding that
did not require a reoperation. The neurologic deficit did
not improve with spinal drainage and hemodynamic sup-
port, and the patient subsequently died of sepsis after
discharge to a rehabilitation center.
Both patients with paraparesis developed bilateral
weakness with return of right lower extremity function with
supportive maneuvers (one immediate and one delayed). A
partial cord infarct was documented by magnetic resonance
Table I. Patient clinical and demographic features
Variable Mean  SD or No. (%) (n  179)
Age, years 73  8
Male gender 112 (63)
Hypertension 153 (86)
History of tobacco use 147 (83)
Any cardiac diseasea 89 (50)
Myocardial infarction 34 (19)
Congestive heart failure 14 (8)
Arrhythmia 22 (12)
Peripheral vascular disease 40 (23)
COPD 45 (25)
Diabetes 18 (10)
Stroke (CVA) 23 (13)
Family history of AAA 19 (11)
Chronic renal insufficiencyb 32 (18)
Creatinine, mg/dL 1.4  0.7
eGFR, mL/min/1.73m2 56  21
AAA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary
disease; CVA, cerebrovascular accident; eGFR, estimated glomerular filtra-
tion rate; SD, standard deviation.
aMyocardial infarction  congestive heart failure  arrhythmia.
bCreatinine 1.8 mg/dL
Table II. Anatomic features
Feature Mean  SD or No. (%) (n  179)
Aneurysm size, cm 6.3  1.1
Degenerative pathology 168 (94)
Symptomatic 32 (18)
Urgent 24 (13)
Ruptured 15 (8)
Previous aneurysm repaira 52 (29)
Single functioning kidney 10 (6)
SD, Standard deviation.
aIncludes 47 previous infrarenal abdominal aortic aneurysm and 5 proximal
thoracoabdominal aortic aneurysm repairsimaging in both instances. 9The 30-day clinical outcomes are further summarized
n Table IV. Given the low event rates for individual com-
lications, composite outcomes of any cardiac complica-
ion, any pulmonary complication, and any renal complica-
ion are also reported (Table IV). At least one cardiac,
ulmonary, renal, or other major complication (any com-
lication) developed in 45 patients (25%).
Multivariate modeling of clinical, anatomic, and tech-
ical features identified independent predictors of the com-
osite outcomes. Only a history of cardiac disease (odds
atio [OR], 11.3; 95% confidence interval [CI], 1.3-10)
trongly predicted the likelihood of a cardiac complication.
ndependent predictors of pulmonary complications in-
luded aneurysm rupture (OR, 5.1; 95% CI, 1.3-19.6),
istory of cardiac disease (OR, 4.2; 95% CI, 1.6-11.2),
istory of chronic obstructive pulmonary disease (OR, 3.8;
able III. Technical details
eature Mean  SD or No. (%) (n  179)
tandard reconstruction 166 (93)
erebrospinal fluid drain 27 (15)
pidural cooling 22 (12)
trial femoral bypass 2 (1)
ight renal stent 33 (19)
plenectomy 57 (32)
R time, min 290  90
otal clamp time, min 82  26
schemia time, min
Visceral 36  12
Left renal 57  19
stimated blood loss, mL 2700  1600
rystalloid, mL 2800  1600
ell saver, mL 960  1000
acked red blood cells, units 3.7  2.3
resh frozen plasma, units 3.4  3.1
latelets, units 3.1  4.5
ntra-op urine output, mL 510  330
D, Standard deviation.
able IV. Clinical outcomes
eature No. (%) (n  179)
n-hospital death 5 (2.8)
yocardial infarction 6 (3.4)
rrhythmia 9 (5)
ny cardiac complication 13 (7)
neumonia 15 (8.4)
rolonged ventilation (48 h) 13 (7)
racheostomy 9 (5)
ny pulmonary complication 33 (18)
enal failure
Without hemodialysis 8 (4.5)
Hemodialysis-dependent 5 (2.8)
ny renal complication 36 (20)
pinal cord ischemia 4 (2.2)
e-exploration 8 (4.5)
epsis 3 (1.6)
ultiorgan failure 2 (1.1)
ny complication 45 (25)5% CI, 1.5-9.9), and total cross-clamp time (OR, 1.06;
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Volume 53, Number 6 Patel et al 149595%CI, 1.02-1.1). Renal complications weremore likely to
occur in patients with a history of CRI (OR, 5.5; 95% CI,
1.4-22.3) and aneurysm rupture (OR, 6.6; 95% CI, 1.3-
33). The sole independent predictor of the composite
outcome of any complication or death included a history of
CRI (OR, 3.4; 95% CI, 1.4-8).
Patients who survived the perioperative period had a
favorable long-term survival (Fig). Kaplan-Meier survival
analysis showed survival rates were 89%  2% at 1 year and
62%  4% at 5 years. Cox proportional hazard analysis did
not identify any perioperative features or postoperative
complications to predict long-term survival.
DISCUSSION
TAAA aneurysm repair has been associated with signif-
icant morbidity and mortality, with a major emphasis in the
literature on reduction of SCI and death. A benchmark
series of Crawford and colleagues1 of TAAA repair reported
significant rates of SCI (16%) and mortality (9%). Recent,
large, single-center reports have presented significant im-
provements in results, most notably in the realm of SCI
complications.2-4 Most studies have reported the outcomes
of Crawford type I through IV TAAA repairs, and the
outcomes of type IV repair in such series have been favor-
able compared with type I to III TAAA repairs.3,4
Contemporary success of TAAA repair is attributed to
Fig. Actuarial survival is shown for patients underg
0 1
Survival % 100 89
At risk 176 136
Standard error 0 2.4the introduction and use of protective adjuncts, such as CSFD, distal perfusion, neuroprotective techniques (epi-
ural cooling, intercostal reimplantation), and neuromoni-
oring, among others.12-18 Patients undergoing type IV
epair uniformly have a very low risk of SCI independent of
djunct use (Table V). In light of our own early experience
nd the findings of other investigators, neuroprotective
djuncts of epidural cooling and CSFD during repair of
ype IV TAAA have been largely abandoned. Regression
nalysis did not identify any predictive or protective oper-
tive factors for development of SCI; however, this may be
elated to the low number of events in our cohort and may
eflect a type 2 statistical error.
Safi et al22 recommend routine use of CSFD and distal
erfusion for all TAAA, including type IV. This group
eported on the benefit of CSFD, noting a significant
eduction in SCI and death with the institution of a com-
ined adjunct consisting of CSFD, passive hypothermia
32°-34°C), and distal aortic perfusion. Using this adjunct
ombination, they effectively reduced SCI rates for TAAA
epair, with most of the benefit derived from reduction of
CI in TAAA types I and II from 31% to 9% overall.23 The
verall SCI rates were reduced to 3.3%; however, this
enefit was not applicable to type IV repair, which was
lready associated with a low incidence of SCI.
Given the relatively low morbidity associated with
type IV thoracoabdominal aortic aneurysm repair.
2 3 4 5
81 76 68 62
114 95 76 64
3.1 3.5 4.0 4.3oingSFD,24 and the evidence supporting its use in general for
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type IV TAAA in accordance with the anticipated proximal
extent of the resection. Despite the low risk of SCI with
type IV repair, Safi et al advocate routine use of distal
perfusion in type IV repair and continue to use such ad-
juncts in 80% of such patients, arguing in favor of a
multiorgan protective strategy. However, a more compli-
cated surgical approach compared with the simplified strat-
egy that we advocate here may explain the increased mor-
tality rate for type IV repair reported by this group.7
Despite continued emphasis on a simplified operative
approach for type IV TAAA, we have recently reported a
shift in operative approach for extent I to III TAAA.26
Achouh et al7 recently reported their experience with neu-
romonitoring (somatosensory evoked potentials) in con-
junction with distal perfusion during thoracic abdominal
and TAAA.7 In their series of consecutive patients under-
going TAAA and DTA repair, type IV patients comprised
16% of the patient cohort. Despite use of neuromonitoring
and distal perfusion, SCI for type IV repair was noted to be
2.7%. This is comparable to SCI reported in other series,
including our current cohort, where such adjuncts were not
routinely used4-6,19,20 (Table V).
Moreover, despite the hypothetical multiorgan protec-
tive strategy associated with adjunct use, the operative
mortality of type IV repair using distal perfusion and neu-
romonitoring was 18%, which was substantial.7 This in-
creased operative mortality rate reflects a more complicated
operative management, which in addition to the aforemen-
tioned adjuncts also included somatosensory evoked po-
tential monitoring and routine reimplantation of (T8-T12)
intercostals. The routine use of distal perfusion or neu-
romonitoring, or both, for type IV repair is therefore
unlikely to improve SCI and likely predisposes patients to a
more extensive operation and associated complications,
including increased mortality.
A theoretic argument can be made in favor of distal
perfusion as an adjunct to reduce renal and visceral ischemia
and specifically prevent renal failure, which is often corre-
lated with increased perioperative mortality.6,27,28 Consis-
tent with the literature, our data show that preoperative
renal insufficiency strongly predicts postoperative renal
complications.6,27,28 Indeed, this rationale accounted for
Table V. Summary of outcomes for type IV thoracoabdom
First author Pts No. Adjuncts
Coselli4 427 None reported
Current series 179 Epidural cooling
CSFD
Kieffer5 174 Distal perfusion:
Bicknell1 130 None
Achouh7 73 CSFD, distal perfusion, SSEP
Schwartz19 58 CSFD
Richards20 44 None
Cina21 42 None
CSFD, Cerebrospinal fluid drainage, SCI, spinal cord ischemia; SSEP, somathe two cases of distal aortic perfusion used in this study. rur renal ischemia times were comparable to those re-
orted by others,6,20,21 and multivariate modeling did not
eveal renal ischemia time as an independent predictor of
enal complications. In prior work27 and with the caveat of
ypothermic perfusion, the risk of renal complications as-
ociated with renal ischemia was only noted at ischemia
imes of 100 minutes, which is well above the mean
6-minute ischemia time in this series.
Repair in the setting of aneurysm rupture was also an
ndependent predictor of renal complications in our current
tudy. Patients undergoing urgent or emergent surgery for
ymptomatic or ruptured aneurysms are more likely to have
ompromised systemic hemodynamics, resulting in sys-
emic malperfusion and renal parenchymal dysfunction.
Regional hypothermia alone is sufficient for renal pro-
ection, as evidenced by a 3% requirement for postoper-
tive hemodialysis, a figure that compares favorably with
he extant literature, despite similarities in baseline demo-
raphics, urgency of presentation, and similar renal isch-
mia times.5,6,20,21,29 Cold crystalloid infusion in the preser-
ation of renal function during complex aortic reconstruction
s well established.30,31
The outcomes of type IV repair using our standardized
pproach are favorable; our operative mortality was 2.8%
literature range, 3%-18%; Table V), and SCI of any degree
ccurred in 2.2% (range, 3%-10%) of patients, with perma-
ent paraplegia in 1%.3-5,7,19-21 Our operative mortality for
ype IV TAAA repair was also favorable compared with the
ortality rates of about 4.7% for open AAA repair as
eported in the Comparison of Endovascular Aneurysm
epair with Open Repair in Patients with Abdominal Aor-
ic Aneurysm (EVAR-1) and Dutch Randomised Endovas-
ular Aneurysm Management (DREAM) trials.32,33 Our
atients had similar demographics and clinical features to
hose of other published series, and factors known to
egatively affect operative mortality, such as CRI and urgent
resentation, were also similarly distributed in this cohort.4-
,19-21,30 Our favorable operative mortality is likely a result of
ur consistent and simplified operative strategy, which was
sed in 93% of type IV repairs in this series.
Schwartz et al19 noted reduced operative mortality asso-
iated with increased operator and institutional experience.
oselli et al,4 with the largest published experience of TAAA
aortic aneurysm repair
No. (%) SCI No. (%) In-hospital death No. (%)
. . . 6 (1.4) 13 (3)
22 (12) 4 (2.2) 5 (2.8)
27 (15)
11 (6.4) 8 (4.7) 23 (13)
5 (3.9) 26 (20)
73 (100) 2 (2.7) 13 (18)
21 (36) 2 (3.4) 2 (5.3)
. . . 1 (2) 3 (6)
. . . 0 2 (4.8)
ory evoked potential monitoring.inalepairs worldwide, reported a similar operativemortality of 3%
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TAAA repairs (all Crawford types), including 427 type IV,
emphasizing operative expediency and efficiency with a sim-
plified operative approach as we have advocated here.4
Using a similar and consistently applied (all patients)
operative approach, Richards et al20 similarly noted low
operative mortality of 6% associated with type IV repair.
They reported excellent outcomes (Table V) with a com-
paratively much smaller experience, further supporting the
importance of a uniform approach to management of type
IV TAAA. Since inception of the Scottish National TAAA
service, their institution was referred all complex aneurysms
for repair during a 10-year period. Although their reported
experience was much smaller (n  53) and also included
repair of suprarenal AAA, the operative reconstruction in-
volved supraceliac cross-clamp application, a single visceral
and right renal ischemia time, and was performed without
CSFD or distal perfusion. Thus, a consistent theme is
evident with respect to a simplified approach to type IV
repairs producing favorable results.
On the contrary, Keiffer et al5 and Bicknell et al6
reported significantly higher mortality rates of 13% and
20%, respectively. Keiffer et al5 noted significantly reduced
operative mortality associated with one of the two primary
surgeons contributing to their data set, implying the obvi-
ous influence of operator experience. Their cohort also
included 26 patients (15%) with nondegenerative aneurysm
pathology such as mycotic aneurysms, vasculitis, dissection,
andMarfan syndrome. Type IV repair in such patients often
requires a more complicated reconstruction, with higher
associated morbidity and mortality. Indeed, these investi-
gators identified the presence of visceral vessel bypasses, in
addition to that to the left renal artery, as predictors of
mortality. Bicknell et al6 noted increased visceral ischemia
strongly predicted operative mortality. Complicated prox-
imal reconstruction and surgeon inexperience can both
contribute to increased ischemia times and may have con-
tributed to the higher operative mortality reported by these
groups. In addition, the high operative mortality reported
by Bicknell et al may have resulted from a higher proportion
of urgent repairs, a reported predictor of operative mortal-
ity in TAAA repair.34 They reported urgent repair in 25% of
their cohort compared with 13% in this series.
The contribution of totally endovascular repair to type
IV TAAA is as yet unknown because this technology is
evolving and not widely available. A recent report of endo-
vascular TAAA repairs (62% type IV) by Roselli, et al35
reported comparable outcomes, with 93% technical suc-
cess, 30-day mortality of 5.5%, 2.7% SCI, and 1.4% hemo-
dialysis. Alternatively, the experience with hybrid repair for
type IV lesions compares poorly with the results reported
here.36,37 We eschew the concept that a hybrid operation
affords a less morbid approach because the visceral deb-
ranching component is an equivalent surgical insult to
conventional type IV repair. In addition, the endovascular
repair component will sacrifice more intercostal vessels,
potentially increasing the risk for SCI.The major limitation of our study is its retrospective
ature, thus introducing the possibility of selection and obser-
ation biases. Observational biases cannot be excluded; how-
ver, theymay have been reduced by the prospective nature of
ata entry into our TACdatabase. These data were entered by
ndividuals not directly involved in the care of the study
atients, thus reducing the chance of data misclassification.
Our favorable outcomes may be reflective of highly
elected patients who were referred for repair as a result of
heir good health. This possibility is supported by the
ong-term survival of our cohort, their 5-year survival was
omparable to that of patients undergoing EVAR for
AA.38,39 Other investigators, however, have similarly re-
orted good long-term survival in patients tolerating type
V repair.20,29 Our study population was demographically
nd clinically similar to those reported by others, arguing
gainst patient selection as the primary factor in our favor-
ble results.6,7,19-22
This study is also limited by the lack of long-term
utcomes for anatomic durability, quality of life, and func-
ional status of patients undergoing type IV repair. Our
wn previous report on anatomic follow-up of all TAAA
types I to IV) noted durable long-term results with a low
.9% incidence of anatomic complications referable to the
ortic reconstruction.40 Beyond the perioperative period,
here postoperative complications and length of stay have
een shown to reduce quality of life, aneurysm extent has
een shown to have no effect on long-term quality of life.41
hese factors warrant further investigation because they
ill be important determinants in clinical decision making
s endovascular technologies evolve.
ONCLUSIONS
The repair of type IV TAAA, using a standardized,
redominantly clamp-and-sew operative approach, contin-
es to produce favorable results. Patient clinical features
trongly affect the outcomes of type IV repair, and patients
olerating operative reconstruction can expect good long-
erm survival. These data may serve as a reference perfor-
ance standard as totally endovascular repair emerges.
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